Veracyte Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.00 billion, with shareholders equity totaling $1.43 billion.
The company employs approximately 755 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Veracyte Inc. reported $581.78 million in revenue, generating net income of $126.85 million.
Key financial metrics include a P/E ratio of 15.74, a price-to-book (P/B) ratio of 1.39, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VCYT.